Key Points
- These stocks are currently priced below $100.
- Netflix, despite a dip this year, retains strong growth fundamentals.
- Pfizer and Verizon offer attractive high dividend yields and discounted valuations.
Investing during market downturns can be rewarding for long‑term investors. The focus should be on a company’s future prospects rather than short‑term price movements. Acquiring stocks with solid fundamentals at a discount can create significant value over time.
The following three companies—Netflix (NASDAQ: NFLX), Pfizer (NYSE: PFE) and Verizon Communications (NYSE: VZ)—are all trading under $100 and present compelling buying opportunities today.
Image source: Getty Images.
Netflix
As a leading streaming service, Netflix has faced headwinds this year. Market concerns about its strategic direction and recent leadership changes have pressured the share price. However, the company’s business remains robust. At roughly $74 per share and trading at about 24‑times trailing earnings, the valuation appears reasonable. Netflix generated $45 billion in revenue last year—a 34 % increase over two years—while delivering $11 billion in earnings, indicating strong profit margins. The firm’s business model is well‑established, and its current price offers a solid entry point for long‑term investors.
Pfizer
Pfizer has hovered in the lower ranks of the market for several years. Despite a forward price‑to‑earnings multiple of just eight and a dividend yield of 7.1 %, investor attention has waned. Trading near $24—a level last seen in 2012—the stock reflects lingering concerns about the longevity of its dividend and overall growth prospects. Recent acquisitions have expanded its pipeline, and the company is advancing roughly 20 pivotal studies this year. Even modest positive clinical data could trigger a rally. Pfizer’s entrenched position in healthcare, history of innovation, and stable earnings outlook make it a safer bet than it appears, especially for investors willing to hold through the short‑term volatility.
Verizon Communications
Verizon, another high‑yielding telecom, has also underperformed in 2026. The share is around $42 with a forward P/E near eight and a dividend yield of about 6.7 %. The company consistently reports over $130 billion in annual revenue, providing a stable cash flow. Its recent acquisition of Frontier is expected to accelerate growth. As a dominant, low‑volatility holding, Verizon serves as a cornerstone for diversified portfolios.
Considerations for Pfizer Investors
Before adding Pfizer to a portfolio, investors should weigh the analyst consensus. The Motley Fool Stock Advisor team recently highlighted ten stocks they consider the best current opportunities; Pfizer was not among them.
Historical performance of recommended picks underscores the potential upside. For instance, a $1,000 investment in Netflix following its 2004 recommendation would have grown to $398,160, while a similar investment in Nvidia after its 2005 recommendation would have reached $1,249,202.
Stock Advisor’s average return since inception stands at 918 %, outperforming the S&P 500’s 209 % gain. Investors seeking a curated list of high‑potential stocks and a community‑driven investing perspective may find value in exploring the service.
Disclaimer: The author holds no positions in the mentioned securities. The Motley Fool maintains positions in Netflix and Pfizer and recommends Verizon Communications. This article does not constitute investment advice. The views expressed are those of the author and do not necessarily reflect those of Nasdaq, Inc.
